New study tracks blood thinner use in infants and toddlers
NCT ID NCT05900388
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 33 times
Summary
This study collects information from medical records of up to 850 children under 2 years old who have blood clots (VTE) and are being treated with rivaroxaban (Xarelto) or other standard blood thinners. Researchers will track how these medicines are prescribed, how long they are used, and whether any serious bleeding occurs. No extra tests or visits are needed—only existing health data is reviewed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
Multiple Locations, Denmark
-
Many locations
Multiple Locations, France
-
Many locations
Multiple Locations, Spain
-
Many locations
Multiple Locations, Sweden
Conditions
Explore the condition pages connected to this study.